BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24128084)

  • 21. Recent advances in the understanding of mastocytosis: the role of KIT mutations.
    Orfao A; Garcia-Montero AC; Sanchez L; Escribano L;
    Br J Haematol; 2007 Jul; 138(1):12-30. PubMed ID: 17555444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous mastocytosis in Thai children.
    Singalavanija S; Limpongsanurak W
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S143-6. PubMed ID: 19253510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of KIT D816V in peripheral blood of children with manifestations of cutaneous mastocytosis suggests systemic disease.
    Carter MC; Bai Y; Ruiz-Esteves KN; Scott LM; Cantave D; Bolan H; Eisch R; Sun X; Hahn J; Maric I; Metcalfe DD
    Br J Haematol; 2018 Dec; 183(5):775-782. PubMed ID: 30488427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD).
    Sotlar K; Colak S; Bache A; Berezowska S; Krokowski M; Bültmann B; Valent P; Horny HP
    J Pathol; 2010 Apr; 220(5):586-95. PubMed ID: 20112369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solitary mastocytoma occurring at a site of trauma.
    Tuxen AJ; Orchard D
    Australas J Dermatol; 2009 May; 50(2):133-5. PubMed ID: 19397569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of the c-kit D816V mutation in systemic mastocytosis by allele-specific PCR.
    Schumacher JA; Elenitoba-Johnson KS; Lim MS
    J Clin Pathol; 2008 Jan; 61(1):109-14. PubMed ID: 17526803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KIT polymorphisms and mutations determine responses of neoplastic mast cells to bafetinib (INNO-406).
    Peter B; Hadzijusufovic E; Blatt K; Gleixner KV; Pickl WF; Thaiwong T; Yuzbasiyan-Gurkan V; Willmann M; Valent P
    Exp Hematol; 2010 Sep; 38(9):782-91. PubMed ID: 20685234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis.
    Wasag B; Niedoszytko M; Piskorz A; Lange M; Renke J; Jassem E; Biernat W; Debiec-Rychter M; Limon J
    Exp Hematol; 2011 Aug; 39(8):859-65.e2. PubMed ID: 21689725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mastocytosis - an update.
    Amon U; Hartmann K; Horny HP; Nowak A
    J Dtsch Dermatol Ges; 2010 Sep; 8(9):695-711; quiz 712. PubMed ID: 20678151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis.
    Erben P; Schwaab J; Metzgeroth G; Horny HP; Jawhar M; Sotlar K; Fabarius A; Teichmann M; Schneider S; Ernst T; Müller MC; Giehl M; Marx A; Hartmann K; Hochhaus A; Hofmann WK; Cross NC; Reiter A
    Ann Hematol; 2014 Jan; 93(1):81-8. PubMed ID: 24281161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. c-kit mutational analysis in paraffin material.
    Sotlar K
    Methods Mol Biol; 2013; 999():59-78. PubMed ID: 23666690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous mastocytosis in children: a clinical analysis of 71 cases.
    Kiszewski AE; Durán-Mckinster C; Orozco-Covarrubias L; Gutiérrez-Castrellón P; Ruiz-Maldonado R
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):285-90. PubMed ID: 15096137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cutaneous mastocytosis].
    Flageul B
    Rev Prat; 2006 Oct; 56(16):1745-51. PubMed ID: 17315498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F.
    Sotlar K; Bache A; Stellmacher F; Bültmann B; Valent P; Horny HP
    J Mol Diagn; 2008 Jan; 10(1):58-66. PubMed ID: 18165278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A solitary mastocytoma presenting with urticaria and angioedema in a 14-year-old boy.
    Krishnan KR; Ownby DR
    Allergy Asthma Proc; 2010; 31(6):520-3. PubMed ID: 21708063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of Stem Cell Factor in Feline Mast Cell Tumour.
    Sakurai M; Iwasa R; Sakai Y; Chambers JK; Uchida K; Morimoto M
    J Comp Pathol; 2018 Aug; 163():6-9. PubMed ID: 30213375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A CHILD CASE OF DIFFUSE CUTANEOUS MASTOCYTOSIS].
    Hoshino Y; Yoshida K; Numata T; Ito T; Egusa C; Maeda T; Sakai N; Harada K; Okubo Y
    Arerugi; 2022; 71(5):397-401. PubMed ID: 35831165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Status and clinical analysis of c-kit and PDGFRA mutations in the gastrointestinal stromal tumors].
    Du CY; Shi YQ; Zhou Y; Fu H; Zhao GF
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):371-5. PubMed ID: 18636362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST).
    Du CY; Shi YQ; Zhou Y; Fu H; Zhao G
    J Surg Oncol; 2008 Sep; 98(3):175-8. PubMed ID: 18618605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of internal tandem duplications in the c-kit of dogs with multiple mast cell tumours.
    Amagai Y; Tanaka A; Matsuda A; Jung K; Oida K; Nishikawa S; Jang H; Matsuda H
    J Small Anim Pract; 2013 Jul; 54(7):377-80. PubMed ID: 23614673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.